Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.58 - $4.99 $39,824 - $77,025
-15,436 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$3.93 - $7.7 $60,663 - $118,857
15,436 New
15,436 $60,000
Q1 2022

May 20, 2022

SELL
$3.93 - $7.7 $15,951 - $31,254
-4,059 Reduced 20.82%
15,436 $61,000
Q4 2021

Feb 16, 2022

BUY
$7.1 - $12.82 $923 - $1,666
130 Added 0.67%
19,495 $138,000
Q3 2021

Nov 12, 2021

SELL
$7.64 - $12.49 $6,830 - $11,166
-894 Reduced 4.41%
19,365 $213,000
Q2 2021

Aug 12, 2021

SELL
$8.68 - $27.49 $442 - $1,401
-51 Reduced 0.25%
20,259 $176,000
Q1 2021

May 03, 2021

SELL
$12.0 - $27.64 $7,212 - $16,611
-601 Reduced 2.87%
20,310 $309,000
Q4 2020

Feb 12, 2021

BUY
$11.05 - $16.62 $12,508 - $18,813
1,132 Added 5.72%
20,911 $244,000
Q2 2020

Aug 10, 2020

SELL
$9.75 - $17.6 $4,992 - $9,011
-512 Reduced 2.52%
19,779 $311,000
Q1 2020

May 15, 2020

BUY
$7.54 - $17.05 $23,630 - $53,434
3,134 Added 18.27%
20,291 $234,000
Q4 2019

Feb 14, 2020

SELL
$6.71 - $9.55 $5,079 - $7,229
-757 Reduced 4.23%
17,157 $157,000
Q3 2019

Nov 12, 2019

BUY
$6.0 - $9.6 $8,070 - $12,912
1,345 Added 8.12%
17,914 $161,000
Q2 2019

Aug 14, 2019

BUY
$3.77 - $8.67 $62,465 - $143,653
16,569 New
16,569 $139,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.